Catalyst Wire Dossier Catalyst Wire Dossier

an experimental chemotherapy combination

· Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for an experimental chemotherapy combination, covering 2019-04-03 to 2019-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer [Phase 2]

See pricing